Palvella Therapeutics PVLA
NASDAQ PVLA
$132.47 -0.26 (-0.20%)
At close: Oct 2, 2026 · 4:00 PM EDT

Palvella Therapeutics (PVLA) Sales of Property, Plant and Equipment (2017 - 2024)

Updated

Palvella Therapeutics (PVLA) recorded Sales of Property, Plant and Equipment of $142,000 in Q3 2024.

Analysis

Palvella Therapeutics (PVLA) Sales of Property, Plant and Equipment (2017 - 2024) Analysis & Trends

For FY2016, Palvella Therapeutics reported Sales of Property, Plant and Equipment of $20,968.

  • The Q3 2024 figure is the lowest quarterly Sales of Property, Plant and Equipment since Q3 2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Sale) (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 63.00 Mn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 49.00 Mn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 4.00 Mn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Palvella Therapeutics 1.91 Bn 1.66 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 142,000.00
Sep 30, 2017 190.00
API Access

Palvella Therapeutics Sales of Property, Plant and Equipment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sales-of-property-plant-and-equipment&ticker=PVLA&period=max&api_key=YOUR_API_KEY